D80.0 Billable / specific Hereditary hypogammaglobulinemia
ICD-10-CM D80.0 identifies “Hereditary hypogammaglobulinemia” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Code-level instructions
Inclusion terms2
- Autosomal recessive agammaglobulinemia (Swiss type)
- X-linked agammaglobulinemia [Bruton] (with growth hormone deficiency)
Inherited instructions
Chapters 3 · Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Excludes 29
- autoimmune disease (systemic) NOS (M35.9)
- certain conditions originating in the perinatal period (P00-P96)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- human immunodeficiency virus [HIV] disease (B20)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
D80-D89 · Certain disorders involving the immune mechanism (D80-D89)
Includes3
- defects in the complement system
- immunodeficiency disorders, except human immunodeficiency virus [HIV] disease
- sarcoidosis
Excludes 12
Excludes 21
human immunodeficiency virus [HIV] disease (B20)
Official index references
Official index references (14)
Absence(of) (organ or part) (complete or partial) (1)
Agammaglobulinemia(acquired (secondary)) (nonfamilial) (6)
- Agammaglobulinemia(acquired (secondary)) (nonfamilial) › autosomal recessive(Swiss type)Disease index
- Agammaglobulinemia(acquired (secondary)) (nonfamilial) › Bruton's X-linkedDisease index
- Agammaglobulinemia(acquired (secondary)) (nonfamilial) › congenital sex-linkedDisease index
- Agammaglobulinemia(acquired (secondary)) (nonfamilial) › hereditaryDisease index
- Agammaglobulinemia(acquired (secondary)) (nonfamilial) › Swiss type(autosomal recessive)Disease index
- Agammaglobulinemia(acquired (secondary)) (nonfamilial) › X-linked(with growth hormone deficiency) (Bruton)Disease index
Bruton's X-linked agammaglobulinemia (1)
- Bruton's X-linked agammaglobulinemiaDisease index
Deficiency, deficient (1)
Hypogammaglobulinemia (1)
- Hypogammaglobulinemia › hereditaryDisease index
Immunodeficiency (1)
- Immunodeficiency › autosomal recessive, Swiss typeDisease index
Syndrome (3)
References from other codes (1)
Excludes 1 · autosomal recessive agammaglobulinemia (Swiss type) (D80.0)
History
Code history
Latest recorded change · FY2027
ChangedUnchanged
FY2027Selected edition
Effective from
- Inherited rules changed
Hereditary hypogammaglobulinemia
Billable diagnosis code
CDC/NCHS · FY2027All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | Inherited rules changed |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | Inherited rules changed |
Historical ICD-9 mappings · 2018
Historical mapping only; not an automatic code substitution.
- 279.04
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.